Global Generic Oncology Drugs Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1205

In 2018, the global Generic Oncology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Generic Oncology Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
GlaxoSmithKline
Novartis
Merck
Celgene
Teva Pharmaceutical
Mylan
Aurobindo Pharma
Hikma Pharmaceuticals
Natco Pharma

Market segment by Type, the product can be split into
Large Molecule Drugs
Small Molecule Drugs

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key players.
To present the Generic Oncology Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Generic Oncology Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Generic Oncology Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Large Molecule Drugs
1.4.3 Small Molecule Drugs
1.5 Market by Application
1.5.1 Global Generic Oncology Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Generic Oncology Drugs Market Size
2.2 Generic Oncology Drugs Growth Trends by Regions
2.2.1 Generic Oncology Drugs Market Size by Regions (2014-2025)
2.2.2 Generic Oncology Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Generic Oncology Drugs Market Size by Manufacturers
3.1.1 Global Generic Oncology Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Generic Oncology Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Generic Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Generic Oncology Drugs Key Players Head office and Area Served
3.3 Key Players Generic Oncology Drugs Product/Solution/Service
3.4 Date of Enter into Generic Oncology Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Generic Oncology Drugs Market Size by Type (2014-2019)
4.2 Global Generic Oncology Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Generic Oncology Drugs Market Size (2014-2019)
5.2 Generic Oncology Drugs Key Players in United States
5.3 United States Generic Oncology Drugs Market Size by Type
5.4 United States Generic Oncology Drugs Market Size by Application

6 Europe
6.1 Europe Generic Oncology Drugs Market Size (2014-2019)
6.2 Generic Oncology Drugs Key Players in Europe
6.3 Europe Generic Oncology Drugs Market Size by Type
6.4 Europe Generic Oncology Drugs Market Size by Application

7 China
7.1 China Generic Oncology Drugs Market Size (2014-2019)
7.2 Generic Oncology Drugs Key Players in China
7.3 China Generic Oncology Drugs Market Size by Type
7.4 China Generic Oncology Drugs Market Size by Application

8 Japan
8.1 Japan Generic Oncology Drugs Market Size (2014-2019)
8.2 Generic Oncology Drugs Key Players in Japan
8.3 Japan Generic Oncology Drugs Market Size by Type
8.4 Japan Generic Oncology Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Generic Oncology Drugs Market Size (2014-2019)
9.2 Generic Oncology Drugs Key Players in Southeast Asia
9.3 Southeast Asia Generic Oncology Drugs Market Size by Type
9.4 Southeast Asia Generic Oncology Drugs Market Size by Application

10 India
10.1 India Generic Oncology Drugs Market Size (2014-2019)
10.2 Generic Oncology Drugs Key Players in India
10.3 India Generic Oncology Drugs Market Size by Type
10.4 India Generic Oncology Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Generic Oncology Drugs Market Size (2014-2019)
11.2 Generic Oncology Drugs Key Players in Central & South America
11.3 Central & South America Generic Oncology Drugs Market Size by Type
11.4 Central & South America Generic Oncology Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Generic Oncology Drugs Introduction
12.1.4 Pfizer Revenue in Generic Oncology Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Generic Oncology Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Generic Oncology Drugs Introduction
12.3.4 Novartis Revenue in Generic Oncology Drugs Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Generic Oncology Drugs Introduction
12.4.4 Merck Revenue in Generic Oncology Drugs Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Generic Oncology Drugs Introduction
12.5.4 Celgene Revenue in Generic Oncology Drugs Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Generic Oncology Drugs Introduction
12.6.4 Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2014-2019)
12.6.5 Teva Pharmaceutical Recent Development
12.7 Mylan
12.7.1 Mylan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Generic Oncology Drugs Introduction
12.7.4 Mylan Revenue in Generic Oncology Drugs Business (2014-2019)
12.7.5 Mylan Recent Development
12.8 Aurobindo Pharma
12.8.1 Aurobindo Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Generic Oncology Drugs Introduction
12.8.4 Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2014-2019)
12.8.5 Aurobindo Pharma Recent Development
12.9 Hikma Pharmaceuticals
12.9.1 Hikma Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Generic Oncology Drugs Introduction
12.9.4 Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2014-2019)
12.9.5 Hikma Pharmaceuticals Recent Development
12.10 Natco Pharma
12.10.1 Natco Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Generic Oncology Drugs Introduction
12.10.4 Natco Pharma Revenue in Generic Oncology Drugs Business (2014-2019)
12.10.5 Natco Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details